Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2018 | New drugs for CML: are more to come?

Speaking from the American Society of Oncology (ASCO) 2018, held in Chicago, IL, Michael Mauro, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, talks about the future uses of asciminib and other novel drugs currently being developed for chronic myeloid leukemia (CML), before mentioning his hopes for the future of this disease with regards to patient remission.